HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator

FEBS Journal

Volumn 281, Issue 13, 2014, Pages 3061-3078

  Bhattacharya, Seemana ^a   Ghosh, Mrinal K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

deubiquitination; glioma; herpes virus associated ubiquitin specific protease; murine double minute 2; Rb

Indexed keywords

DEUBIQUITINASE; HERPES VIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; PROTEIN MDM2; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CYCLE G1 PHASE; CELL POPULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME MECHANISM; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

HERPESVIRIDAE; MURINAE;

DEUBIQUITINATION; GLIOMA; HERPES VIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; MURINE DOUBLE MINUTE 2; RB;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GLIOMA; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84903819539     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12843     Document Type: Article

References (58)

1. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, &, Dryja TP, (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646.
2. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, &, Lee EY, (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394-1399.
3. Fattman CL, An B, &, Dou QP, (1997) Characterization of interior cleavage of retinoblastoma protein in apoptosis. J Cell Biochem 67, 399-408.
4. Yee AS, Shih HH, &, Tevosian SG, (1998) New perspectives on retinoblastoma family functions in differentiation. Front Biosci 3, D532-D547.
5. Dick FA, &, Rubin SM, (2013) Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol 14, 297-306.
6. Medema RH, Herrera RE, Lam F, &, Weinberg RA, (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92, 6289-6293.
7. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, &, Livingston DM, (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085-1095.
8. Delston RB, Matatall KA, Sun Y, Onken MD, &, Harbour JW, (2011) p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis. Oncogene 30, 588-599.
9. Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, &, La Thangue NB, (2001) Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3, 667-674.
10. Saddic LA, West LE, Aslanian A, Yates JR, Rubin SM, Gozani O, &, Sage J, (2010) Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem 285, 37733-37740.
11. Ledl A, Schmidt D, &, Müller S, (2005) Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 24, 3810-3818.
12. Ying H, &, Xiao Z-XJ, (2006) Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 5, 506-508.
13. Ventii KH, &, Wilkinson KD, (2008) Protein partners of deubiquitinating enzymes. Biochem J 414, 161.
14. Uchida C, Miwa S, Kitagawa K, Hattori T, Isobe T, Otani S, Oda T, Sugimura H, Kamijo T, Ookawa K, et al,. (2005) Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J 24, 160-169.
15. Sdek P, Ying H, Chang DLF, Qiu W, Zheng H, Touitou R, Allday MJ, &, Xiao Z-XJ, (2005) MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell 20, 699-708.
16. Zheng Z, Li L, Liu X, Wang D, Tu B, Wang L, Wang H, &, Zhu W-G, (2012) 5-Aza-2′-deoxycytidine reactivates gene expression via degradation of pRb pocket proteins. FASEB J 26, 449-459.
17. Nitta RT, Smith CL, &, Kennedy BK, (2007) Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. PLoS One 2, e963.
18. Nitta RT, Jameson SA, Kudlow BA, Conlan LA, &, Kennedy BK, (2006) Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest. Mol Cell Biol 26, 5360-5372.
19. Li CG, Nyman JE, Braithwaite AW, &, Eccles MR, (2011) PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene 30, 4824-4834.
20. Nicholson B, &, Suresh Kumar KG, (2011) The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys 60, 61-68.
21. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, &, Cavenee WK, (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48, 5546-5551.
22. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, &, Louis DN, (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36, 714-721.
23. Rao SK, Edwards J, Joshi AD, Siu I-M, &, Riggins GJ, (2010) A survey of glioblastoma genomic amplifications and deletions. J Neurooncol 96, 169-179.
24. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al,. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683-2710.
25. Lee SH, Kim JH, Rhee CH, Kang YS, Lee JH, Hong SI, &, Choi KS, (1995) Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas. J Korean Med Sci 10, 442-448.
26. Louis DN, &, Gusella JF, (1995) A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11, 412-415.
27. Biernat W, Kleihues P, Yonekawa Y, &, Ohgaki H, (1997) Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 56, 180-185.
28. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, et al,. (2002) Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res 8, 180-187.
29. Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y, &, Abe H, (1998) Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms. Cancer Res 58, 609-613.
30. Masciullo V, Khalili K, &, Giordano A, (2000) The Rb family of cell cycle regulatory factors: clinical implications. Int J Oncol 17, 897-902.
31. Huang Z, Wu Q, Guryanova OA, Cheng L, Shou W, Rich JN, &, Bao S, (2011) Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol 13, 142-152.
32. Everett RD, Meredith M, Orr A, Cross A, Kathoria M, &, Parkinson J, (1997) A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16, 566-577.
33. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, &, Gu W, (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653.
34. Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK, &, Varshavsky A, (1989) A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576-1583.
35. Huang HJ, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EY, &, Lee WH, (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563-1566.
36. Becker K, Marchenko ND, Palacios G, &, Moll UM, (2008) A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle 7, 1205-1213.
37. Li M, Brooks CL, Kon N, &, Gu W, (2004) A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13, 879-886.
38. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J, &, Pandolfi PP, (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813-817.
39. Van der Horst A, de Vries-Smits AMM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, &, Burgering BMT, (2006) FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol 8, 1064-1073.
40. Ronai Z, (2006) Balancing Mdm2-a Daxx-HAUSP matter. Nat Cell Biol 8, 790-791.
41. Yap DB, Hsieh JK, Chan FS, &, Lu X, (1999) mdm2: a bridge over the two tumour suppressors, p53 and Rb. Oncogene 18, 7681-7689.
42. Blanchette P, Gilchrist CA, Baker RT, &, Gray DA, (2001) Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130. Oncogene 20, 5533-5537.
43. Dick FA, (2007) Structure-function analysis of the retinoblastoma tumor suppressor protein-is the whole a sum of its parts? Cell Div 2, 26.
44. Kulathu Y, &, Komander D, (2012) Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 13, 508-523.
45. Sdek P, Ying H, Zheng H, Margulis A, Tang X, Tian K, &, Xiao Z-XJ, (2004) The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth. J Biol Chem 279, 53317-53322.
46. Hunter T, (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 28, 730-738.
47. Cheng C, Niu C, Yang Y, Wang Y, &, Lu M, (2013) Expression of HAUSP in gliomas correlates with disease progression and survival of patients. Oncol Rep 29, 1730-1736.
48. Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J, et al,. (2009) Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther 8, 2286-2295.
49. Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V, Harpon J, Battaglia V, Vivat V, Sippl W, et al,. (2012) Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol 19, 467-477.
50. Yamaguchi M, Miyazaki M, Kodrasov MP, Rotinsulu H, Losung F, Mangindaan REP, de Voogd NJ, Yokosawa H, Nicholson B, &, Tsukamoto S, (2013) Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor. Bioorg Med Chem Lett 23, 3884-3886.
51. Burkhart DL, &, Sage J, (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8, 671-682.
52. Paul I, Ahmed SF, Bhowmik A, Deb S, &, Ghosh MK, (2013) The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene 32, 1284-1295.
53. Ahmed SF, Deb S, Paul I, Chatterjee A, Mandal T, Chatterjee U, &, Ghosh MK, (2012) The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. J Biol Chem 287, 15996-16006.
54. Guturi KKN, Mandal T, Chatterjee A, Sarkar M, Bhattacharya S, Chatterjee U, &, Ghosh MK, (2012) Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells. J Biol Chem 287, 18287-18296.
55. Mahul-Mellier A-L, Pazarentzos E, Datler C, Iwasawa R, AbuAli G, Lin B, &, Grimm S, (2012) De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ 19, 891-899.
56. Strayhorn WD, &, Wadzinski BE, (2002) A novel in vitro assay for deubiquitination of I kappa B alpha. Arch Biochem Biophys 400, 76-84.
57. Chatterjee A, Chatterjee U, &, Ghosh MK, (2013) Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer. Cell Death Dis 4, e543.
58. Bhowmik A, Das N, Pal U, Mandal M, Bhattacharya S, Sarkar M, Jaisankar P, Maiti NC, &, Ghosh MK, (2013) 2,2′-diphenyl-3,3′-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway. PLoS One 8, e59798.